On January 10, 2022, Bioxytran, Inc. closed the transaction. The company has issued securities pursuant to Regulation D from 34 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.101 USD | -3.02% | -14.04% | -32.67% |
1st Jan change | Capi. | |
---|---|---|
-32.67% | 16.82M | |
+2.56% | 108B | |
+10.02% | 104B | |
+6.96% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |
- Stock
- Equities
- Stock Bioxytran, Inc. - OTC Markets
- News Bioxytran, Inc.
- Bioxytran, Inc. announced that it has received $1.467 million in funding